Literature DB >> 916891

Membranous lupus nephropathy: a clinicopathologic study.

J V Donadio, J H Burgess, K E Holley.   

Abstract

Twenty-eight patients with SLE and distinct, well-defined renal morphologic lesions of membranous nephropathy were followed up for 4 years. These patients comprised approximately 8% of the patients evaluated for SLE during a 12-year period. The patients with membranous lupus nephropathy had typical systemic features of SLE, and most of them had positive LE cell tests and ANA, low serum complement concentrations, and mildly elevated serum antinative DNA levels. Proteniuria and microscopic hematuria were usually discovered years after systemic symptoms of SLE had developed, Only two patients had slowly progressive renal failure, and most patients continued to have proteinuria. Prednisone treatment did not influence either proteinuria or renal function. In only one patient, the renal character of the disease changed drastically, demonstrating membranoproliferative glomerulonephritis. Six patients died (21%); most of these died of cardiovascular illnesses. The relatively benign and stable renal course of membranous lupus nephropathy in patients with otherwise typical SLE suggests that the renal pathogenesis is different from that of proliferative lupus nephritis.

Entities:  

Mesh:

Year:  1977        PMID: 916891     DOI: 10.1097/00005792-197711000-00007

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  12 in total

1.  Hemocytopenia as initial manifestation of systemic lupus erythematosus. Prognostic significance.

Authors:  C Lavalle; R Hurtado; J J Quezada; A Cabral; A Fraga
Journal:  Clin Rheumatol       Date:  1983-09       Impact factor: 2.980

Review 2.  The treatment of lupus nephritis.

Authors:  J S Cameron
Journal:  Pediatr Nephrol       Date:  1989-07       Impact factor: 3.714

Review 3.  [Renal manifestations of rheumatic diseases].

Authors:  A Schwarting; E Märker-Hermann
Journal:  Z Rheumatol       Date:  2005-02       Impact factor: 1.372

4.  Randomized, controlled trial of prednisone, cyclophosphamide, and cyclosporine in lupus membranous nephropathy.

Authors:  Howard A Austin; Gabor G Illei; Michelle J Braun; James E Balow
Journal:  J Am Soc Nephrol       Date:  2009-03-18       Impact factor: 10.121

5.  Lupus-like membranous nephropathy: Is it lupus or not?

Authors:  Ramin Sam; Amit Joshi; Sam James; Kuang-Yu Jen; Firouz Amani; Peter Hart; Melvin M Schwartz
Journal:  Clin Exp Nephrol       Date:  2014-07-04       Impact factor: 2.801

6.  IgG4 deposits in pure and combined membranous lupus nephritis.

Authors:  David Herrera van Oostdam; Marco U Martínez Martínez; Cuauhtémoc Oros-Ovalle; David Martínez-Gala; Gerardo T Jaimes Piñón; Carlos Abud Mendoza
Journal:  Clin Rheumatol       Date:  2016-05-02       Impact factor: 2.980

Review 7.  Membranous nephropathy in systemic lupus erythematosus: a therapeutic enigma.

Authors:  Chi Chiu Mok
Journal:  Nat Rev Nephrol       Date:  2009-04       Impact factor: 28.314

Review 8.  Lupus nephritis in childhood and adolescence.

Authors:  J S Cameron
Journal:  Pediatr Nephrol       Date:  1994-04       Impact factor: 3.714

9.  Parasites alter the pathological phenotype of lupus nephritis.

Authors:  Katsuhisa Miyake; Keishi Adachi; Maho Watanabe; Yoshie Sasatomi; Satoru Ogahara; Yasuhiro Abe; Kenji Ito; Yombo K Dan Justin; Takao Saito; Hitoshi Nakashima; Shinjiro Hamano
Journal:  Autoimmunity       Date:  2014-06-24       Impact factor: 2.815

10.  Chapter 12: Lupus nephritis.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2012-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.